The PEERLESS II Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1200 participants.
Also called NCT06055920
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 1,200 participants
- Sponsor
- Registry
-
NCT06055920
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States, Belgium, Canada, Denmark, France, Germany, Spain, Switzerland
- Registry status
- Completed
Technical summary
Registry record NCT06055920. Randomized; no masking; primary purpose treatment. Start 2023-11-17 (actual); primary completion 2026-07-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The PEERLESS II Study
- Condition
- Pulmonary Embolism
- Intervention (Device)
- FlowTriever System
- Intervention (Drug)
- Anticoagulation Agents
- Lead sponsor
- Inari Medical
Record details
- Record id
cardio:ct-nct06055920- Content hash
1a2987056d7abb22af3d1585986157c4e3f8bc856f48881ea38644397cc8f144